Amber Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Amber Therapeutics's estimated annual revenue is currently $3.8M per year.
- Amber Therapeutics's estimated revenue per employee is $77,500
- Amber Therapeutics's total funding is $101M.
Employee Data
- Amber Therapeutics has 49 Employees.
- Amber Therapeutics grew their employee count by 40% last year.
Amber Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, CEO | Reveal Email/Phone |
2 | Co-founder & Chief Scientist | Reveal Email/Phone |
3 | CMO | Reveal Email/Phone |
4 | VP Regulatory, Clinical, Quality | Reveal Email/Phone |
5 | Director R&D | Reveal Email/Phone |
6 | Director Clinical Affairs | Reveal Email/Phone |
7 | Hardware & Systems Engineering Manager | Reveal Email/Phone |
8 | Senior Supply Chain Manager | Reveal Email/Phone |
9 | Quality Operations Manager | Reveal Email/Phone |
10 | Finance Manager | Reveal Email/Phone |
Amber Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 22 | 10% | N/A | N/A |
#2 | $2.1M | 27 | 13% | N/A | N/A |
#3 | $0.5M | 6 | -14% | N/A | N/A |
#4 | $3.6M | 46 | 21% | N/A | N/A |
#5 | $2.2M | 28 | 0% | $21.8M | N/A |
#6 | $2.1M | 27 | 0% | N/A | N/A |
#7 | $5.7M | 73 | 4% | $37.7M | N/A |
#8 | $2.4M | 31 | 19% | $191M | N/A |
#9 | $1.9M | 24 | 50% | N/A | N/A |
#10 | $3.6M | 46 | 18% | $21.9M | N/A |
What Is Amber Therapeutics?
Amber Therapeutics is a University of Oxford spinout developing next-generation, intelligent bioelectrical therapies to transform clinical outcomes in patients with functional disorders of the peripheral nervous system. Amber’s approach leverages closed-loop intelligence to create ‘synthetic reflex arcs’ that can sense, interpret, adapt and respond to a patient’s individual signals thereby restoring normal physiological function. Amber Therapeutics was founded by a multidisciplinary team of clinicians, translational neuroengineers, medtech industry professionals and experienced entrepreneurs focused on developing transformational therapy innovation for major unmet medical conditions. The Company was spun out from the University of Oxford in 2021 and is backed by Oxford Science Enterprises and 8VC.
keywords:N/A$101M
Total Funding
49
Number of Employees
$3.8M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.1M | 49 | 4% | N/A |
#2 | $8M | 49 | 17% | N/A |
#3 | $6.5M | 49 | -8% | N/A |
#4 | $4.7M | 49 | 26% | N/A |
#5 | $8.9M | 49 | 14% | N/A |